Modified gemcitabine and oxaliplatin or gemcitabine plus cisplatin in unresectable gallbladder cancer: Results of a phase III randomised controlled trial

Sharma, A; Mohanti, BK; Chaudhary, SP; Sreenivas, V; Sahoo, RK; Shukla, NK; Thulkar, S; Pal, S; Deo, SV; Pathy, S; Dash, NR; Kumar, S; Bhatnagar, S; Kumar, R; Mishra, S; Sahni, P; Iyer, VK; Raina, V

Sharma, A (reprint author), AIIMS, Dept Med Oncol, Dr BRA IRCH, New Delhi 110029, India.

EUROPEAN JOURNAL OF CANCER, 2019; 123 (): 162

Abstract

Aim: To determine equivalence of modified gemcitabine and oxaliplatin compared with gemcitabine and cisplatin in unresectable gallbladder cancer (GBC)......

Full Text Link